Glycyrrhizic acid suppresses cox-2-mediated anti-inflammatory responses during Leishmania donovani infection

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 8, 2012, Pages 1905-1914

  Bhattacharjee, Surajit ^a,b   Bhattacharjee, Amrita ^a   Majumder, Saikat ^a   Majumdar, Suchandra Bhattacharya ^a   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

^b TRIPURA UNIVERSITY   (India)

Author keywords

Cytokines; Immunomodulators; Macrophages; Nitric oxide; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; GLYCYRRHIZIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; IN VIVO STUDY; LIQUID SCINTILLATION COUNTING; LIVER; MACROPHAGE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GLYCYRRHIZIC ACID; IMMUNOLOGIC FACTORS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN; TREATMENT OUTCOME;

EID: 84864502747     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks159     Document Type: Article

References (48)

1. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006; 19: 111-26.
2. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 2001; 6: 849-54.
3. Pifferi G, Vitali R. Medicines from plants. Chim Indust 1993; 75: 380-4.
4. Chan-Bacab MJ, Peña-Rodríguez LM. Plant natural products with leishmanicidal activity. Nat Prod Rep 2001; 18: 674-88.
5. Davis EA, Morris DJ. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol Cell Endocrinol 1991; 78: 1-6.
6. Ody P. The Complete Medicinal Herbal. New York: Dorling Kindersley, 1993.
7. Hatano T, Kagawa H, Yasuhara T et al. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chem Pharm Bull (Tokyo) 1988; 36: 2090-7.
8. Tyler VE. Medicinal plant research: 1953-1987. Planta Med 1988; 54: 95-100.
9. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 1997; 23: 302-13.
10. Fu Y, Hsieh TC, Guo J et al. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 2004; 322: 263-70.
11. Tolstikov GA, Baltina LA, Shults EE et al. [Glycyrrhizic acid]. Bioorg Khim 1997; 23: 691-709.
12. Chen M, Christensen SB, Theander TG et al. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob Agents Chemother 1994; 38: 1339-44.
13. Ukil A, Biswas A, Das T et al. 18b-Glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kB. J Immunol 2005; 175: 1161-9.
14. Abe N, Ebina T, Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 1982; 26: 535-9.
15. Baba M, Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res 1987; 7: 99-107.
16. Guo N. Protective effect of glycyrrhizine in mice with systemic Candida albicans infection and its mechanism. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1991; 13: 380-3.
17. Suzuki F, Schmitt DA, Utsunomiya T et al. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo 1992; 6: 589-96.
18. Badam L. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis 1997; 29: 91-9.
19. Majumdar S. A process for preparing pure glycyrrhizic acid from licorice. Patent Application No. 771/KOL/2005, Govt of India, International Classification No. A61K/31/00, 2006.
20. Hart DT, Vickerman K, Coombs GH. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 1981; 82: 345-55.
21. Fahey TJ, Tracey KJ, Tekamp-Olson P et al. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 1992; 148: 2764-9.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
23. Das L, Datta N, Bandyopadhyay S et al. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol 2001; 166: 4020-8.
24. Dasgupta S, Mookerjee A, Chowdhury SK et al. Immunosuppression in hamsters with progressive visceral leishmaniasis: an evaluation of the role of nitric oxide toward impairment of the lymphoproliferative response. Parasitol Res 1999; 85: 594-6.
25. Green LC, Wagner DA, Glogowski J et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
26. Hibbs JB, Taintor RR, Vavrin Z et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87-94.
27. Majumdar S, Kane LH, Rossi MW et al. Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent b-PKC and novel calcium-independent nPKC. Biochim Biophys Acta 1993; 1176: 276-86.
28. Ghosh S, Bhattacharyya S, Sirkar M et al. Leishmania donovani suppresses activated protein 1 and NF-kB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect Immun 2002; 70: 6828-38.
29. Roy S, Scherer MT, Briner TJ et al. Murine MHC polymorphism and T cell specificities. Science 1989; 244: 572-5.
30. Olivier M, Gregory DJ, Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 2005; 18: 293-305.
31. Marotta P, Sautebin L, Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 1992; 107: 640-1.
32. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146: 108-13.
33. Gregory DJ, Sladek R, Olivier M et al. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun 2008; 76: 1186-92.
34. Reiner NE, Malemud CJ. Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell Immunol 1984; 88: 501-10.
35. Farrell JP, Kirkpatrick CE. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol 1987; 138: 902-7.
36. Heinzel FP, Sadick MD, Mutha SS et al. Production of interferon g, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991; 88: 7011-5.
37. Reiner NE, Ng W, McMaster WR. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol 1987; 138: 1926-32.
38. Carvalho EM, Teixeira RS, Johnson WD. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 1981; 33: 498-500.
39. Gifawesen C, Farrell JP. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect Immun 1989; 57: 3091-6.
40. Haldar JP, Ghose S, Saha KC et al. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun 1983; 42: 702-7.
41. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-16.
42. Trebino CE, Stock JL, Gibbons CP et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 2003; 100: 9044-9.
43. Klingemann HG, Tsoi MS, Storb R. Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting. Blood 1986; 68: 102-7.
44. Harbrecht BG, Kim YM, Wirant EA et al. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-g-induced macrophage NO synthesis by PGE2. J Leukoc Biol 1997; 61: 712-20.
45. Griffon B, Cillard J, Chevanne M et al. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. Hepatology 1998; 28: 1300-8.
46. McSorley S, Proudfoot L, O'Donnell CA et al. Immunology of murine leishmaniasis. Clin Dermatol 1996; 14: 451-64.
47. Descoteaux A, Matlashewskig G. c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol Cell Biol 1989; 9: 5223-7.
48. Taylor AP, Murray HW. Intracellular antimicrobial activity in the absence of interferon-g: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-g gene-disrupted mice. J Exp Med 1997; 185: 1231-9.